{"gene":"POLR3GL","run_date":"2026-04-28T19:45:44","timeline":{"discoveries":[{"year":2013,"finding":"POLR3GL and POLR3G arose from a DNA-based gene duplication in a common ancestor of vertebrates, resulting in two distinct Pol III isoforms. Both POLR3GL- and POLR3G-containing Pol III occupy the same target genes in very constant proportions within a cell line, indicating similar target gene specificity. However, unlike POLR3G, the POLR3GL promoter does not bind the transcription factor MYC, demonstrating neofunctionalization at the level of transcriptional regulation rather than protein function.","method":"ChIP-seq genome-wide occupancy profiling, promoter-binding assays, phylogenetic/genomic analysis of gene duplication","journal":"Genome research","confidence":"High","confidence_rationale":"Tier 1-2 — genome-wide ChIP-seq with multiple cell lines and normal tissue, replicated across conditions, identifying both shared target gene occupancy and differential MYC promoter binding","pmids":["24107381"],"is_preprint":false},{"year":2019,"finding":"POLR3GL is ubiquitously expressed whereas POLR3G is enriched in undifferentiated/cancer cells. Selective depletion of POLR3GL does not trigger proliferative arrest or differentiation of prostate cancer cells, in contrast to POLR3G depletion, establishing that the two Pol III isoforms have functionally distinct roles in controlling cell fate despite occupying the same target genes.","method":"siRNA-mediated knockdown of POLR3GL vs. POLR3G with proliferation and differentiation assays in prostate cancer cell lines","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — clean selective KD with specific phenotypic readouts (proliferation arrest, differentiation), replicated across multiple cell lines","pmids":["30820548"],"is_preprint":false},{"year":2020,"finding":"POLR3GL-containing Pol III (Pol IIIβ) and POLR3G-containing Pol III (Pol IIIα) bind the same target genes and perform the same transcriptional functions both in vitro and in vivo, and can compensate for each other to a significant degree. POLR3GL knockout mice complete embryonic development but die ~3 weeks after birth with growth defects and potential cerebellar neuronal defects, demonstrating that POLR3GL is essential for postnatal viability. Exogenous POLR3GL expression rescues the differentiation defect of POLR3G knockout embryonic stem cells.","method":"Knockout mouse generation, embryonic stem cell differentiation assays, in vitro transcription assays, ChIP-seq","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — in vivo knockout phenotyping combined with in vitro rescue experiments and ChIP-seq, multiple orthogonal methods","pmids":["32576691"],"is_preprint":false},{"year":2022,"finding":"Loss of POLR3G (RPC7α) but not POLR3GL (RPC7β) leads to a restricted repertoire of Pol III-transcribed genes, with snaR-A noncoding RNA being particularly sensitive to POLR3G loss. POLR3GL-containing Pol III cannot maintain snaR-A transcription at levels equivalent to POLR3G-containing Pol III, indicating that the two isoforms have distinct transcriptional outputs at specific loci despite shared target occupancy.","method":"POLR3G knockout, ChIP-seq, RNA-seq, analysis of chromatin features at Pol III target genes","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — KO with multiple orthogonal genomic readouts (ChIP-seq, RNA-seq) establishing isoform-specific transcriptional repertoire differences","pmids":["35637192"],"is_preprint":false},{"year":2019,"finding":"During skeletal muscle differentiation in Xenopus, Polr3gL (the ortholog of POLR3GL) is upregulated alongside contractile protein genes, while Polr3g is expressed early in the myogenic lineage. The two isoforms have distinct activities on tRNA isoacceptor synthesis as shown by custom tRNA microarray. Forcing Polr3g expression during differentiation partially reverses myogenic differentiation, while Pol III-dependent transcripts are dramatically downregulated during muscle differentiation.","method":"tRNA microarray, expression analysis during Xenopus embryonic development, Polr3g overexpression in differentiating muscle cells","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional overexpression with phenotypic readout and tRNA microarray in a vertebrate model, but single lab study in Xenopus","pmids":["31173763"],"is_preprint":false},{"year":2019,"finding":"Biallelic loss-of-function splice acceptor site variants in POLR3GL cause loss of full-length POLR3GL RNA transcripts (confirmed by RNA sequencing), resulting in a clinical syndrome of axial endosteal hyperostosis, oligodontia, short stature, and mild facial dysmorphisms, establishing POLR3GL as an essential Pol III subunit in human skeletal and dental development.","method":"Whole exome sequencing, RNA sequencing to confirm nonsense-mediated decay/aberrant splicing of POLR3GL transcripts in patient blood","journal":"European journal of human genetics : EJHG","confidence":"Medium","confidence_rationale":"Tier 2 — RNA-seq confirmation of loss-of-function in patients establishes molecular mechanism, but no in vitro functional reconstitution","pmids":["31089205"],"is_preprint":false},{"year":2019,"finding":"A homozygous nonsense variant in POLR3GL (p.Arg120Ter) leads to nonsense-mediated decay of POLR3GL transcripts (confirmed by RNA studies), causing a variant of neonatal progeroid syndrome, further establishing the essential in vivo role of POLR3GL as a subunit of RNA polymerase III in human development.","method":"Exome sequencing, RNA expression studies demonstrating nonsense-mediated decay","journal":"European journal of human genetics : EJHG","confidence":"Medium","confidence_rationale":"Tier 2 — RNA studies confirm loss-of-function mechanism at transcript level in a patient","pmids":["31695177"],"is_preprint":false},{"year":2023,"finding":"Structural and genomic studies reveal that POLR3GL (RPC7β) and POLR3G (RPC7α) have distinct protein characteristics, and that Pol III identity (determined by which RPC7 subunit is incorporated) underlies differential Pol III transcription patterns. The two subunits are mutually exclusively incorporated into the Pol III complex.","method":"Review integrating structural data and genomic studies; mutually exclusive subunit incorporation established by prior biochemical fractionation and ChIP-seq","journal":"Frontiers in molecular biosciences","confidence":"Medium","confidence_rationale":"Tier 2 — review synthesizing prior structural and genomic data confirming mutually exclusive incorporation; not a primary experimental paper","pmids":["36710885"],"is_preprint":false}],"current_model":"POLR3GL encodes the RPC7β subunit that is incorporated mutually exclusively with the paralog POLR3G (RPC7α) into RNA polymerase III, forming two distinct Pol III isoforms (Pol IIIα and Pol IIIβ) that occupy the same genomic target genes but differ in transcriptional output at specific loci (e.g., snaR-A), in regulation (POLR3G but not POLR3GL is controlled by MYC), and in developmental expression (POLR3GL is ubiquitous while POLR3G is enriched in stem and cancer cells); POLR3GL is essential for postnatal survival in mice and for normal human skeletal and dental development, and the two isoforms can partially compensate for each other in vivo."},"narrative":{"teleology":[{"year":2013,"claim":"Establishing that POLR3GL and POLR3G arose by DNA-based gene duplication and encode interchangeable Pol III subunits that occupy the same target genes resolved the question of whether two RPC7 paralogs have divergent or redundant target specificity, revealing that neofunctionalization occurred at the level of transcriptional regulation (MYC binding) rather than target gene selection.","evidence":"ChIP-seq occupancy profiling, promoter-binding assays, and phylogenomic analysis in multiple human cell lines","pmids":["24107381"],"confidence":"High","gaps":["Whether any loci show quantitative differences in transcription between the two isoforms was not resolved","Mechanism by which MYC regulation of POLR3G but not POLR3GL impacts Pol III output was unexplored","In vivo consequences of losing either isoform were unknown"]},{"year":2019,"claim":"Demonstrating that POLR3G depletion but not POLR3GL depletion triggers proliferative arrest and differentiation in cancer cells, and that the two isoforms differ in expression across differentiation states, established that the paralogs have functionally distinct roles in cell fate control despite shared target occupancy.","evidence":"siRNA knockdown with proliferation/differentiation assays in prostate cancer cells [PMID:30820548]; tRNA microarray and expression analysis during Xenopus muscle differentiation [PMID:31173763]","pmids":["30820548","31173763"],"confidence":"High","gaps":["Which specific Pol III transcript changes mediate the differentiation phenotype was not identified","Whether the isoform switch during differentiation is cause or consequence of lineage commitment was unresolved"]},{"year":2019,"claim":"Identification of biallelic loss-of-function variants in POLR3GL in patients with skeletal dysplasia/oligodontia and neonatal progeroid syndrome established POLR3GL as essential for human skeletal and dental development and demonstrated that POLR3G cannot fully compensate for POLR3GL loss in these tissues.","evidence":"Whole-exome sequencing with RNA-seq confirmation of nonsense-mediated decay/aberrant splicing in patient samples","pmids":["31089205","31695177"],"confidence":"Medium","gaps":["No in vitro functional reconstitution or cellular rescue experiments were performed","Which Pol III transcripts are specifically disrupted in affected tissues is unknown","Single-family studies without independent replication for each variant"]},{"year":2020,"claim":"Knockout mouse studies resolved the in vivo essentiality question: POLR3GL is dispensable for embryogenesis but required for postnatal survival, and exogenous POLR3GL rescues POLR3G-knockout ES cell differentiation defects, proving partial functional interchangeability of the two isoforms.","evidence":"POLR3GL knockout mice, ES cell differentiation rescue, in vitro transcription, and ChIP-seq","pmids":["32576691"],"confidence":"High","gaps":["Precise cause of postnatal lethality (cerebellar vs. systemic growth failure) was not definitively resolved","Whether double knockout is embryonic lethal was not tested","Tissue-specific requirements for each isoform remain unmapped"]},{"year":2022,"claim":"Demonstrating that POLR3G loss restricts the Pol III transcriptional repertoire at specific loci (notably snaR-A) while POLR3GL-containing Pol III cannot maintain equivalent output resolved how two isoforms sharing target genes produce distinct transcriptional outcomes.","evidence":"POLR3G knockout with ChIP-seq, RNA-seq, and chromatin feature analysis","pmids":["35637192"],"confidence":"High","gaps":["Structural basis for why snaR-A and other loci are preferentially sensitive to isoform identity is unknown","Whether POLR3GL-containing Pol III has its own uniquely dependent loci has not been tested","Downstream functional consequences of snaR-A loss are unclear"]},{"year":null,"claim":"The structural determinants within RPC7β versus RPC7α that confer locus-specific transcriptional differences, the full set of Pol III targets uniquely dependent on each isoform, and the tissue-specific mechanisms underlying the human disease phenotypes of POLR3GL deficiency remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No high-resolution structure of Pol IIIβ (POLR3GL-containing) complex has been solved","Tissue-specific Pol III transcript profiling in POLR3GL-deficient contexts is lacking","Genotype-phenotype correlation across different POLR3GL variants is incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,2,7]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,2,3]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,2,3,4]}],"complexes":["RNA polymerase III"],"partners":["POLR3G"],"other_free_text":[]},"mechanistic_narrative":"POLR3GL encodes RPC7β, a subunit of RNA polymerase III that is incorporated mutually exclusively with its paralog POLR3G (RPC7α), generating two distinct Pol III isoforms (Pol IIIα and Pol IIIβ) that arose from a vertebrate-specific gene duplication [PMID:24107381, PMID:36710885]. Both isoforms occupy the same genomic target genes and can partially compensate for each other in vivo, yet they differ in transcriptional output at specific loci such as snaR-A and in upstream regulation, as MYC controls POLR3G but not POLR3GL [PMID:24107381, PMID:35637192]. POLR3GL is ubiquitously expressed and upregulated during differentiation, whereas POLR3G is enriched in stem and cancer cells; accordingly, POLR3GL knockout mice complete embryogenesis but die postnatally with growth and cerebellar defects [PMID:30820548, PMID:32576691, PMID:31173763]. Biallelic loss-of-function variants in POLR3GL cause human developmental syndromes featuring endosteal hyperostosis, oligodontia, short stature, and neonatal progeroid features [PMID:31089205, PMID:31695177]."},"prefetch_data":{"uniprot":{"accession":"Q9BT43","full_name":"DNA-directed RNA polymerase III subunit RPC7-like","aliases":["DNA-directed RNA polymerase III subunit G-like","RNA polymerase III 32 kDa beta subunit","RPC32-beta"],"length_aa":218,"mass_kda":25.3,"function":"DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Specific peripheric component of RNA polymerase III which synthesizes small RNAs, such as 5S rRNA and tRNAs","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9BT43/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/POLR3GL","classification":"Not Classified","n_dependent_lines":9,"n_total_lines":1208,"dependency_fraction":0.0074503311258278145},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000121851","cell_line_id":"CID000716","localizations":[{"compartment":"nuclear_punctae","grade":3},{"compartment":"nucleoplasm","grade":2}],"interactors":[{"gene":"POLR2K","stoichiometry":10.0},{"gene":"POLR3B","stoichiometry":10.0},{"gene":"POLR3E","stoichiometry":10.0},{"gene":"POLR3F","stoichiometry":10.0},{"gene":"POLR3D","stoichiometry":10.0},{"gene":"POLR3A","stoichiometry":10.0},{"gene":"POLR2E","stoichiometry":10.0},{"gene":"POLR3C","stoichiometry":10.0},{"gene":"CRCP","stoichiometry":4.0},{"gene":"POLR2H","stoichiometry":4.0}],"url":"https://opencell.sf.czbiohub.org/target/CID000716","total_profiled":1310},"omim":[{"mim_id":"619234","title":"SHORT STATURE, OLIGODONTIA, DYSMORPHIC FACIES, AND MOTOR DELAY; SOFM","url":"https://www.omim.org/entry/619234"},{"mim_id":"617457","title":"POLYMERASE III, RNA, SUBUNIT G-LIKE; POLR3GL","url":"https://www.omim.org/entry/617457"},{"mim_id":"617456","title":"POLYMERASE III, RNA, SUBUNIT G; POLR3G","url":"https://www.omim.org/entry/617456"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/POLR3GL"},"hgnc":{"alias_symbol":["flj32422","MGC3200"],"prev_symbol":[]},"alphafold":{"accession":"Q9BT43","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BT43","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BT43-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BT43-F1-predicted_aligned_error_v6.png","plddt_mean":71.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POLR3GL","jax_strain_url":"https://www.jax.org/strain/search?query=POLR3GL"},"sequence":{"accession":"Q9BT43","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BT43.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BT43/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BT43"}},"corpus_meta":[{"pmid":"34395528","id":"PMC_34395528","title":"RNA Polymerase III Subunit Mutations in Genetic Diseases.","date":"2021","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/34395528","citation_count":53,"is_preprint":false},{"pmid":"24107381","id":"PMC_24107381","title":"Gene duplication and neofunctionalization: POLR3G and POLR3GL.","date":"2013","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/24107381","citation_count":46,"is_preprint":false},{"pmid":"30820548","id":"PMC_30820548","title":"Effects on prostate cancer cells of targeting RNA polymerase III.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/30820548","citation_count":38,"is_preprint":false},{"pmid":"34850129","id":"PMC_34850129","title":"The nuclear and cytoplasmic activities of RNA polymerase III, and an evolving transcriptome for surveillance.","date":"2021","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/34850129","citation_count":33,"is_preprint":false},{"pmid":"31089205","id":"PMC_31089205","title":"Biallelic variants in POLR3GL cause endosteal hyperostosis and oligodontia.","date":"2019","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/31089205","citation_count":30,"is_preprint":false},{"pmid":"35637192","id":"PMC_35637192","title":"A cancer-associated RNA polymerase III identity drives robust transcription and expression of snaR-A noncoding RNA.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35637192","citation_count":27,"is_preprint":false},{"pmid":"32576691","id":"PMC_32576691","title":"Functions of paralogous RNA polymerase III subunits POLR3G and POLR3GL in mouse development.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32576691","citation_count":26,"is_preprint":false},{"pmid":"31695177","id":"PMC_31695177","title":"A variant of neonatal progeroid syndrome, or Wiedemann-Rautenstrauch syndrome, is associated with a nonsense variant in POLR3GL.","date":"2019","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/31695177","citation_count":23,"is_preprint":false},{"pmid":"36497214","id":"PMC_36497214","title":"The POLR3G Subunit of Human RNA Polymerase III Regulates Tumorigenesis and Metastasis in Triple-Negative Breast Cancer.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/36497214","citation_count":15,"is_preprint":false},{"pmid":"34447748","id":"PMC_34447748","title":"Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction Model.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34447748","citation_count":15,"is_preprint":false},{"pmid":"37338518","id":"PMC_37338518","title":"Significance of liquid-liquid phase separation (LLPS)-related genes in breast cancer: a multi-omics analysis.","date":"2023","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/37338518","citation_count":13,"is_preprint":false},{"pmid":"31173763","id":"PMC_31173763","title":"Skeletal muscle differentiation drives a dramatic downregulation of RNA polymerase III activity and differential expression of Polr3g isoforms.","date":"2019","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/31173763","citation_count":10,"is_preprint":false},{"pmid":"36710885","id":"PMC_36710885","title":"RNA polymerase III transcription and cancer: A tale of two RPC7 subunits.","date":"2023","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/36710885","citation_count":6,"is_preprint":false},{"pmid":"37894362","id":"PMC_37894362","title":"A Combinatorial Regulatory Platform Determines Expression of RNA Polymerase III Subunit RPC7α (POLR3G) in Cancer.","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/37894362","citation_count":4,"is_preprint":false},{"pmid":"40684265","id":"PMC_40684265","title":"Comprehensive genotype-phenotype analysis in POLR3-related disorders.","date":"2025","source":"HGG advances","url":"https://pubmed.ncbi.nlm.nih.gov/40684265","citation_count":2,"is_preprint":false},{"pmid":"40777011","id":"PMC_40777011","title":"Optimized network inference for immune diseased single cells.","date":"2025","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/40777011","citation_count":0,"is_preprint":false},{"pmid":"38796765","id":"PMC_38796765","title":"[Wiedemann-Rautenstrauch syndrome. The first description of a clinical case in the Russian Federation].","date":"2023","source":"Problemy endokrinologii","url":"https://pubmed.ncbi.nlm.nih.gov/38796765","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8880,"output_tokens":2218,"usd":0.029955},"stage2":{"model":"claude-opus-4-6","input_tokens":5522,"output_tokens":1838,"usd":0.11034},"total_usd":0.140295,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2013,\n      \"finding\": \"POLR3GL and POLR3G arose from a DNA-based gene duplication in a common ancestor of vertebrates, resulting in two distinct Pol III isoforms. Both POLR3GL- and POLR3G-containing Pol III occupy the same target genes in very constant proportions within a cell line, indicating similar target gene specificity. However, unlike POLR3G, the POLR3GL promoter does not bind the transcription factor MYC, demonstrating neofunctionalization at the level of transcriptional regulation rather than protein function.\",\n      \"method\": \"ChIP-seq genome-wide occupancy profiling, promoter-binding assays, phylogenetic/genomic analysis of gene duplication\",\n      \"journal\": \"Genome research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genome-wide ChIP-seq with multiple cell lines and normal tissue, replicated across conditions, identifying both shared target gene occupancy and differential MYC promoter binding\",\n      \"pmids\": [\"24107381\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"POLR3GL is ubiquitously expressed whereas POLR3G is enriched in undifferentiated/cancer cells. Selective depletion of POLR3GL does not trigger proliferative arrest or differentiation of prostate cancer cells, in contrast to POLR3G depletion, establishing that the two Pol III isoforms have functionally distinct roles in controlling cell fate despite occupying the same target genes.\",\n      \"method\": \"siRNA-mediated knockdown of POLR3GL vs. POLR3G with proliferation and differentiation assays in prostate cancer cell lines\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean selective KD with specific phenotypic readouts (proliferation arrest, differentiation), replicated across multiple cell lines\",\n      \"pmids\": [\"30820548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"POLR3GL-containing Pol III (Pol IIIβ) and POLR3G-containing Pol III (Pol IIIα) bind the same target genes and perform the same transcriptional functions both in vitro and in vivo, and can compensate for each other to a significant degree. POLR3GL knockout mice complete embryonic development but die ~3 weeks after birth with growth defects and potential cerebellar neuronal defects, demonstrating that POLR3GL is essential for postnatal viability. Exogenous POLR3GL expression rescues the differentiation defect of POLR3G knockout embryonic stem cells.\",\n      \"method\": \"Knockout mouse generation, embryonic stem cell differentiation assays, in vitro transcription assays, ChIP-seq\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vivo knockout phenotyping combined with in vitro rescue experiments and ChIP-seq, multiple orthogonal methods\",\n      \"pmids\": [\"32576691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Loss of POLR3G (RPC7α) but not POLR3GL (RPC7β) leads to a restricted repertoire of Pol III-transcribed genes, with snaR-A noncoding RNA being particularly sensitive to POLR3G loss. POLR3GL-containing Pol III cannot maintain snaR-A transcription at levels equivalent to POLR3G-containing Pol III, indicating that the two isoforms have distinct transcriptional outputs at specific loci despite shared target occupancy.\",\n      \"method\": \"POLR3G knockout, ChIP-seq, RNA-seq, analysis of chromatin features at Pol III target genes\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with multiple orthogonal genomic readouts (ChIP-seq, RNA-seq) establishing isoform-specific transcriptional repertoire differences\",\n      \"pmids\": [\"35637192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"During skeletal muscle differentiation in Xenopus, Polr3gL (the ortholog of POLR3GL) is upregulated alongside contractile protein genes, while Polr3g is expressed early in the myogenic lineage. The two isoforms have distinct activities on tRNA isoacceptor synthesis as shown by custom tRNA microarray. Forcing Polr3g expression during differentiation partially reverses myogenic differentiation, while Pol III-dependent transcripts are dramatically downregulated during muscle differentiation.\",\n      \"method\": \"tRNA microarray, expression analysis during Xenopus embryonic development, Polr3g overexpression in differentiating muscle cells\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional overexpression with phenotypic readout and tRNA microarray in a vertebrate model, but single lab study in Xenopus\",\n      \"pmids\": [\"31173763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Biallelic loss-of-function splice acceptor site variants in POLR3GL cause loss of full-length POLR3GL RNA transcripts (confirmed by RNA sequencing), resulting in a clinical syndrome of axial endosteal hyperostosis, oligodontia, short stature, and mild facial dysmorphisms, establishing POLR3GL as an essential Pol III subunit in human skeletal and dental development.\",\n      \"method\": \"Whole exome sequencing, RNA sequencing to confirm nonsense-mediated decay/aberrant splicing of POLR3GL transcripts in patient blood\",\n      \"journal\": \"European journal of human genetics : EJHG\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNA-seq confirmation of loss-of-function in patients establishes molecular mechanism, but no in vitro functional reconstitution\",\n      \"pmids\": [\"31089205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A homozygous nonsense variant in POLR3GL (p.Arg120Ter) leads to nonsense-mediated decay of POLR3GL transcripts (confirmed by RNA studies), causing a variant of neonatal progeroid syndrome, further establishing the essential in vivo role of POLR3GL as a subunit of RNA polymerase III in human development.\",\n      \"method\": \"Exome sequencing, RNA expression studies demonstrating nonsense-mediated decay\",\n      \"journal\": \"European journal of human genetics : EJHG\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNA studies confirm loss-of-function mechanism at transcript level in a patient\",\n      \"pmids\": [\"31695177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Structural and genomic studies reveal that POLR3GL (RPC7β) and POLR3G (RPC7α) have distinct protein characteristics, and that Pol III identity (determined by which RPC7 subunit is incorporated) underlies differential Pol III transcription patterns. The two subunits are mutually exclusively incorporated into the Pol III complex.\",\n      \"method\": \"Review integrating structural data and genomic studies; mutually exclusive subunit incorporation established by prior biochemical fractionation and ChIP-seq\",\n      \"journal\": \"Frontiers in molecular biosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — review synthesizing prior structural and genomic data confirming mutually exclusive incorporation; not a primary experimental paper\",\n      \"pmids\": [\"36710885\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POLR3GL encodes the RPC7β subunit that is incorporated mutually exclusively with the paralog POLR3G (RPC7α) into RNA polymerase III, forming two distinct Pol III isoforms (Pol IIIα and Pol IIIβ) that occupy the same genomic target genes but differ in transcriptional output at specific loci (e.g., snaR-A), in regulation (POLR3G but not POLR3GL is controlled by MYC), and in developmental expression (POLR3GL is ubiquitous while POLR3G is enriched in stem and cancer cells); POLR3GL is essential for postnatal survival in mice and for normal human skeletal and dental development, and the two isoforms can partially compensate for each other in vivo.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"POLR3GL encodes RPC7β, a subunit of RNA polymerase III that is incorporated mutually exclusively with its paralog POLR3G (RPC7α), generating two distinct Pol III isoforms (Pol IIIα and Pol IIIβ) that arose from a vertebrate-specific gene duplication [PMID:24107381, PMID:36710885]. Both isoforms occupy the same genomic target genes and can partially compensate for each other in vivo, yet they differ in transcriptional output at specific loci such as snaR-A and in upstream regulation, as MYC controls POLR3G but not POLR3GL [PMID:24107381, PMID:35637192]. POLR3GL is ubiquitously expressed and upregulated during differentiation, whereas POLR3G is enriched in stem and cancer cells; accordingly, POLR3GL knockout mice complete embryogenesis but die postnatally with growth and cerebellar defects [PMID:30820548, PMID:32576691, PMID:31173763]. Biallelic loss-of-function variants in POLR3GL cause human developmental syndromes featuring endosteal hyperostosis, oligodontia, short stature, and neonatal progeroid features [PMID:31089205, PMID:31695177].\",\n  \"teleology\": [\n    {\n      \"year\": 2013,\n      \"claim\": \"Establishing that POLR3GL and POLR3G arose by DNA-based gene duplication and encode interchangeable Pol III subunits that occupy the same target genes resolved the question of whether two RPC7 paralogs have divergent or redundant target specificity, revealing that neofunctionalization occurred at the level of transcriptional regulation (MYC binding) rather than target gene selection.\",\n      \"evidence\": \"ChIP-seq occupancy profiling, promoter-binding assays, and phylogenomic analysis in multiple human cell lines\",\n      \"pmids\": [\"24107381\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether any loci show quantitative differences in transcription between the two isoforms was not resolved\",\n        \"Mechanism by which MYC regulation of POLR3G but not POLR3GL impacts Pol III output was unexplored\",\n        \"In vivo consequences of losing either isoform were unknown\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrating that POLR3G depletion but not POLR3GL depletion triggers proliferative arrest and differentiation in cancer cells, and that the two isoforms differ in expression across differentiation states, established that the paralogs have functionally distinct roles in cell fate control despite shared target occupancy.\",\n      \"evidence\": \"siRNA knockdown with proliferation/differentiation assays in prostate cancer cells [PMID:30820548]; tRNA microarray and expression analysis during Xenopus muscle differentiation [PMID:31173763]\",\n      \"pmids\": [\"30820548\", \"31173763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Which specific Pol III transcript changes mediate the differentiation phenotype was not identified\",\n        \"Whether the isoform switch during differentiation is cause or consequence of lineage commitment was unresolved\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of biallelic loss-of-function variants in POLR3GL in patients with skeletal dysplasia/oligodontia and neonatal progeroid syndrome established POLR3GL as essential for human skeletal and dental development and demonstrated that POLR3G cannot fully compensate for POLR3GL loss in these tissues.\",\n      \"evidence\": \"Whole-exome sequencing with RNA-seq confirmation of nonsense-mediated decay/aberrant splicing in patient samples\",\n      \"pmids\": [\"31089205\", \"31695177\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No in vitro functional reconstitution or cellular rescue experiments were performed\",\n        \"Which Pol III transcripts are specifically disrupted in affected tissues is unknown\",\n        \"Single-family studies without independent replication for each variant\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Knockout mouse studies resolved the in vivo essentiality question: POLR3GL is dispensable for embryogenesis but required for postnatal survival, and exogenous POLR3GL rescues POLR3G-knockout ES cell differentiation defects, proving partial functional interchangeability of the two isoforms.\",\n      \"evidence\": \"POLR3GL knockout mice, ES cell differentiation rescue, in vitro transcription, and ChIP-seq\",\n      \"pmids\": [\"32576691\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Precise cause of postnatal lethality (cerebellar vs. systemic growth failure) was not definitively resolved\",\n        \"Whether double knockout is embryonic lethal was not tested\",\n        \"Tissue-specific requirements for each isoform remain unmapped\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrating that POLR3G loss restricts the Pol III transcriptional repertoire at specific loci (notably snaR-A) while POLR3GL-containing Pol III cannot maintain equivalent output resolved how two isoforms sharing target genes produce distinct transcriptional outcomes.\",\n      \"evidence\": \"POLR3G knockout with ChIP-seq, RNA-seq, and chromatin feature analysis\",\n      \"pmids\": [\"35637192\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for why snaR-A and other loci are preferentially sensitive to isoform identity is unknown\",\n        \"Whether POLR3GL-containing Pol III has its own uniquely dependent loci has not been tested\",\n        \"Downstream functional consequences of snaR-A loss are unclear\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural determinants within RPC7β versus RPC7α that confer locus-specific transcriptional differences, the full set of Pol III targets uniquely dependent on each isoform, and the tissue-specific mechanisms underlying the human disease phenotypes of POLR3GL deficiency remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No high-resolution structure of Pol IIIβ (POLR3GL-containing) complex has been solved\",\n        \"Tissue-specific Pol III transcript profiling in POLR3GL-deficient contexts is lacking\",\n        \"Genotype-phenotype correlation across different POLR3GL variants is incomplete\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 2, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 2, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 2, 3, 4]}\n    ],\n    \"complexes\": [\"RNA polymerase III\"],\n    \"partners\": [\"POLR3G\"],\n    \"other_free_text\": []\n  }\n}\n```"}